Hua Liu

Hua Liu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
WTWei Tan
Wei Tan
JZJie Zhang
Jie Zhang
FDFangfang Dai
Fangfang Dai
DYDongyong Yang
Dongyong Yang
RGRan Gu
Ran Gu
YCYanxiang Cheng
Yanxiang Cheng

24 June 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
XZXi-Zi Zhu
Xi-Zi Zhu
ZDZhi-Min Deng
Zhi-Min Deng
FDFang-Fang Dai
Fang-Fang Dai
HLHua Liu
Hua Liu
YCYan-Xiang Cheng
Yan-Xiang Cheng
Miscarriage is the most common complication of pregnancy. The most common causes of early miscarriage are chromosomal abnormalities of the embryo, maternal endocrine abnormalities, organ malformations, and abnormal immune factors. Late miscarriages are mostly caused by factors such as cervical insufficiency. However, the causes of 50% of miscarriages remain unknown. Recently, increasing attention has been given to the role of metabolic abnormalities in miscarriage. In this review, we mainly discuss the roles of four major metabolic pathways (glucose, lipid, and amino acid metabolism, and oxidation‒reduction balance) in miscarriage and the metabolism-related genes that lead to metabolic disorders in miscarriage. Depending on aetiology, the current treatments for miscarriage include hormonal and immunological drugs, as well as surgery, while there are few therapies for metabolism. Therefore, we also summarize the drugs for metabolism-related targets. The study of altered metabolism underlying miscarriage not only helps us to understand the mechanisms involved in miscarriage but also provides an important basis for clinical research on new therapies.

18 October 2023 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
RGRan Gu
Ran Gu
FDFangfang Dai
Fangfang Dai
CXChunrong Xiang
Chunrong Xiang
JCJing Chen
Jing Chen
DYDongyong Yang
Dongyong Yang
YCYanxiang Cheng
Yanxiang Cheng

7 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WTWei Tan
Wei Tan
GCGantao Chen
Gantao Chen
QCQinyu Ci
Qinyu Ci
ZDZhimin Deng
Zhimin Deng
RGRan Gu
Ran Gu
YCYanxiang Cheng
Yanxiang Cheng
Patients with advanced and recurrent cervical cancer often lack satisfactory treatment outcomes. Thus, it is necessary to seek reliable biomarkers that provide the ability to identify the disease at an early stage and predict the patient prognosis, providing new strategies for the treatment of cervical cancer. The sequencing data of ITGA3 were retrieved from public datasets. Immune infiltration and sensitivity of potential immunotherapy and chemotherapy have been analyzed between two subgroups. Functional analysis was applied to excavate the related pathways of ITGA3 in cervical cancer. Furthermore, the impact of ITGA3 in tumor progression has been verified in vitro. The results revealed that the level of ITGA3 was upregulated in cervical cancer, and was positively correlated with worse prognosis. The tumor microenvironment of patients in the high-risk group was immunosuppressed. Patients in high-risk group may not benefit from immunotherapy, but be may be sensitive to several chemotherapy drugs. Notably, the angiogenesis, epithelial mesenchymal transition, and PI3K pathway were increased in high-risk group. Collectively, ITGA3 is a marker of poor prognosis and promotes tumor progression by regulating PI3K/AKT pathway in cervical cancer. Our results provide new insights for potential molecular targeted therapy and prognostic prediction of cervical cancer.

29 April 2024 in Endocrinology
Verified
Journal Article
Closed access
PDF file
YHYanjie Huang
Yanjie Huang
FDFangfang Dai
Fangfang Dai
LCLiping Chen
Liping Chen
ZLZhidian Li
Zhidian Li
HLHua Liu
Hua Liu
YCYanxiang Cheng
Yanxiang Cheng
Context: Recurrent spontaneous abortion (RSA) is defined as the loss of 2 or more consecutive intrauterine pregnancies with the same sexual partner in the first trimester. Despite its significance, the etiology and underlying mechanisms of RSA remain elusive. Defective decidualization is proposed as one of the potential causes of RSA, with abnormal decidualization leading to disturbances in trophoblast invasion function. Objective: To assess the role of bone morphogenetic protein 4 (BMP4) in decidualization and RSA. Methods: Decidual samples were collected from both RSA patients and healthy controls to assess BMP4 expression. In vitro cell experiments utilized the hESC cell line to investigate the impact of BMP4 on decidualization and associated aging, as well as its role in the maternal-fetal interface communication. Subsequently, a spontaneous abortion mouse model was established to evaluate embryo resorption rates and BMP4 expression levels. Results: Our study identified a significant downregulation of BMP4 expression in the decidua of RSA patients compared to the normal control group. In vitro, BMP4 knockdown resulted in inadequate decidualization and inhibited associated aging processes. Mechanistically, BMP4 was implicated in the regulation of FOXO1 expression, thereby influencing decidualization and aging. Furthermore, loss of BMP4 hindered trophoblast migration and invasion via FOXO1 modulation. Additionally, BMP4 downregulation was observed in RSA mice. Conclusion: Our findings highlighted the downregulation of BMP4 in both RSA patients and mice. BMP4 in human endometrial stromal cells was shown to modulate decidualization by regulating FOXO1 expression. Loss of BMP4 may contribute to the pathogenesis of RSA, suggesting potential avenues for abortion prevention strategies.

29 February 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
ZLZhidian Li
Zhidian Li
FDFangfang Dai
Fangfang Dai
RZRonghui Zhu
Ronghui Zhu
YZYuwei Zhang
Yuwei Zhang
JCJing Chen
Jing Chen
YCYanxiang Cheng
Yanxiang Cheng